Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125747151 | 12574715 | 1 | I | 2016 | 20160714 | 20160720 | 20160720 | EXP | DE-PFIZER INC-2016345683 | PFIZER | 0.00 | N | M | Y | 3.11000 | KG | 20160720 | OT | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125747151 | 12574715 | 1 | PS | VENLAFAXINE HCL | VENLAFAXINE HYDROCHLORIDE | 1 | Transplacental | 225 MG, DAILY | 20699 | 225 | MG | ||||||||
| 125747151 | 12574715 | 2 | SS | VENLAFAXINE HCL | VENLAFAXINE HYDROCHLORIDE | 1 | Transplacental | 150 MG, DAILY | 20699 | 150 | MG | ||||||||
| 125747151 | 12574715 | 3 | SS | AMLODIPINE BESILATE | AMLODIPINE BESYLATE | 1 | Transplacental | 10 MG, DAILY | 19787 | 10 | MG | ||||||||
| 125747151 | 12574715 | 4 | SS | METHYLDOPA. | METHYLDOPA | 1 | Transplacental | 750 MG, DAILY | Y | 0 | 750 | MG | |||||||
| 125747151 | 12574715 | 5 | C | EXFORGE | AMLODIPINE BESYLATEVALSARTAN | 1 | Transplacental | AMLODIPINE BESILATE 10 MG/VALSARTAN 160 MG DAILY | 0 | ||||||||||
| 125747151 | 12574715 | 6 | C | FEMIBION SCHWANGERSCHAFT 2 | 2 | Transplacental | 0.4 MG, 1X/DAY | 0 | .4 | MG | QD | ||||||||
| 125747151 | 12574715 | 7 | C | BISOPROLOL | BISOPROLOL | 1 | Transplacental | 5 MG, 1X/DAY | 0 | 5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125747151 | 12574715 | 1 | Perinatal depression |
| 125747151 | 12574715 | 3 | Hypertension |
| 125747151 | 12574715 | 4 | Hypertension |
| 125747151 | 12574715 | 5 | Hypertension |
| 125747151 | 12574715 | 6 | Vitamin supplementation |
| 125747151 | 12574715 | 7 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125747151 | 12574715 | CA |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125747151 | 12574715 | Aortic valve stenosis | |
| 125747151 | 12574715 | Atrial septal defect | |
| 125747151 | 12574715 | Maternal exposure during pregnancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125747151 | 12574715 | 1 | 20150525 | 201508 | 0 | |
| 125747151 | 12574715 | 2 | 201508 | 20160224 | 0 | |
| 125747151 | 12574715 | 3 | 201507 | 0 | ||
| 125747151 | 12574715 | 4 | 201507 | 201510 | 0 | |
| 125747151 | 12574715 | 5 | 20150525 | 201507 | 0 | |
| 125747151 | 12574715 | 7 | 201510 | 0 |